P507: Clinical role, optimal timing and frequency of measurement of serum infliximab levels and anti-infliximab antibody titres in patients with inflammatory bowel diseaseECCO '16 Amsterdam
2016
P508: Pregnancy outcomes in patients with inflammatory bowel disease experiencing flare ups during foetal developmentECCO '16 Amsterdam
2016
P509: What is the effect of inflammatory bowel disease on sedation rates at colonoscopy?ECCO '16 Amsterdam
2016
P510: Skin anergy and latent tuberculosis in inflammatory bowel disease patientsECCO '16 Amsterdam
2016